甲状旁腺激素下调尿酸转运体ABCG2加重继发性甲状旁腺功能亢进中的尿酸蓄积
在继发性甲状旁腺功能亢进尿毒症大鼠中,血清尿酸升高、肠道和肾脏尿酸排泄减少,伴肠道和肾上皮细胞膜尿酸转运体ABCG2表达下调;钙模拟剂西那卡塞可预防该效应。体外实验显示甲状旁腺激素(1-34)下调Caco-2细胞膜ABCG2表达而mRNA不变,无活性片段(13-34)无此作用。临床研究显示透析继发性甲状旁腺功能亢进患者接受西那卡塞治疗后血清尿酸和甲状旁腺激素水平均显著下降。
要点
- 继发性甲状旁腺功能亢进尿毒症大鼠血清尿酸升高,肠道和肾脏尿酸排泄减少,伴ABCG2表达下调。
- 甲状旁腺激素通过甲状旁腺激素受体转录后下调细胞膜ABCG2表达,减少肠道和肾脏尿酸排泄。
- 西那卡塞可预防动物上述效应,并在透析继发性甲状旁腺功能亢进患者中显著降低血清尿酸和甲状旁腺激素水平。
核心结论
- 甲状旁腺激素下调细胞膜ABCG2表达,抑制肠道和肾脏尿酸排泄,导致尿酸蓄积,西那卡塞治疗可预防该效应。
研究设计与样本
- 研究包括继发性甲状旁腺功能亢进尿毒症大鼠动物实验、肠道Caco-2细胞体外实验,以及透析继发性甲状旁腺功能亢进患者的临床观察。
主要发现
- 尿毒症大鼠血清尿酸水平升高,肠道和肾脏尿酸排泄减少,伴肠道和肾上皮细胞膜ABCG2表达下调。
- 西那卡塞给药可预防尿毒症大鼠上述血清尿酸升高、尿酸排泄减少及ABCG2下调。
- Caco-2细胞中甲状旁腺激素(1-34)下调细胞膜ABCG2表达而mRNA水平不变,无活性片段(13-34)无此作用。
- 透析继发性甲状旁腺功能亢进患者接受西那卡塞治疗后,血清尿酸水平显著降低,同时甲状旁腺激素水平下降。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperuricemia occurs with increasing frequency among patients with hyperparathyroidism. However, the molecular mechanism by which the serum parathyroid hormone (PTH) affects serum urate levels remains unknown. This was studied in uremic rats with secondary hyperparathyroidism where serum urate levels were found to be increased and urate excretion in the intestine and kidney decreased, presumably due to down-regulation of the expression of the urate exporter ABCG2 in intestinal and renal epithelial membranes. These effects were prevented by administration of the calcimimetic cinacalcet, a PTH suppressor, suggesting that PTH may down-regulate ABCG2 expression. This was directly tested in intestinal Caco-2 cells where the expression of ABCG2 on the plasma membrane was down-regulated by PTH (1-34) while its mRNA level remained unchanged. Interestingly, an inactive PTH derivative (13-34) had no effect, suggesting that a posttranscriptional regulatory system acts through the PTH receptor to regulate ABCG2 plasma membrane expression. As found in an animal study, additional clinical investigations showed that treatment with cinacalcet resulted in significant reductions in serum urate levels together with decreases in PTH levels in patients with secondary hyperparathyroidism undergoing dialysis. Thus, PTH down-regulates ABCG2 expression on the plasma membrane to suppress intestinal and renal urate excretion, and the effects of PTH can be prevented by cinacalcet treatment.
引用
- Sugimoto R, Watanabe H, Ikegami K, et al. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney Int. 2016. PMID: 27988213. doi:10.1016/j.kint.2016.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。